Nissay Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
|
|||||
|
2025
Q1 | $1.52M | Buy |
|
|||||
|
2024
Q4 | $1.24M | Buy |
|
|||||
|
2024
Q3 | $1.36M | Buy |
|
|||||
|
2024
Q2 | $1.22M | Buy |
|
|||||
|
2024
Q1 | $1.35M | Buy |
|
|||||
|
2023
Q4 | $1.23M | Buy |
|
|||||
|
2023
Q3 | $1.11M | Buy |
|
|||||
|
2023
Q2 | $1.2M | Buy |
|
|||||
|
2023
Q1 | $1.33M | Sell |
|
|||||
|
2022
Q4 | $1.51M | Sell |
|
|||||
|
2022
Q3 | $1.55M | Buy |
|
|||||
|
2022
Q2 | $1.55M | Buy |
|
|||||
|
2022
Q1 | $1.43M | Buy |
|
|||||
|
2021
Q4 | $1.42M | Buy |
|
|||||
|
2021
Q3 | $685K | Buy |
|
|||||
|
2021
Q2 | $743K | Buy |
|
|||||
|
2021
Q1 | $782K | Buy |
|
|||||
|
2020
Q4 | $644K | Buy |
|